The 'biohacking' trend that has tech workers experimenting on themselves

Дата публикации: 19-01-2026 11:00:00

In an industry known for pushing the bounds of human innovation, tech elites are now trying to push the bounds of their own bodies. The hot new biohacking trend is injectable peptides — similar to the ones found in GLP-1 medications like Ozempic. But these are not approved by the Food and Drug Administration.These gray-market peptides, largely from Chinese manufacturers, are being used by tech workers and founders. Not just to lose weight, but to optimize their health and performance in all manner of ways. “Marketplace Tech” host Meghan McCarty Carino speaks with independent journalist Jasmine Sun, who recently wrote about this for the New York Times.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Startups are betting on a legalized peptide market	0	7	26-05-2026
2	What AI fitness apps can and can't do — for now	0	5	04-02-2026
3	Bytes: Week in Review - Anthropic and the Pentagon face off, OpenAI teams up with consulting firms and Mac Mini moves to the U.S.	0	5	27-02-2026
4	Why SpaceX stock soared, then stumbled	0	7	26-06-2026
5	БАДам под Ozempic прописали выход в онлайн // Насколько опасны имитации препаратов для похудения	-2	7	26-06-2026
6	It's a tough time to break into cybersecurity	-2	5	15-06-2026
7	A former Apple executive is building a $1 billion smart glasses rival to Meta	0	7	06-07-2026
8	Bytes: Week in Review - SpaceX eyes an IPO, community members want legal commitments from Micron, and YouTube to ditch AI slop	0	7	23-01-2026
9	Богатые биохакеры ищут способ жить дольше: есть ли научное обоснование их методам	0	6	26-06-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 5. Источник: www.marketplace.org.